| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1084260A2 Caspase-9 deficient animals and the use thereof |
| 03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084244A1 Tnfr-like protein with death domain |
| 03/21/2001 | EP1084243A2 Protein for regulating apoptosis |
| 03/21/2001 | EP1084242A2 Phagocytic assay method |
| 03/21/2001 | EP1084241A1 G-protein coupled receptor, named 2871 receptor |
| 03/21/2001 | EP1084240A1 Polypeptides with beta-secretase type activity |
| 03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
| 03/21/2001 | EP1084235A1 Human protein c polypeptide |
| 03/21/2001 | EP1084234A2 Human deadenylating nuclease, its production and its use |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/21/2001 | EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/21/2001 | EP1084144A2 Improvements in or relating to uptake of substances by cells |
| 03/21/2001 | EP1084143A1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 03/21/2001 | EP1084142A1 Gpr35a receptor |
| 03/21/2001 | EP1084141A1 nrdF |
| 03/21/2001 | EP1084137A1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1083935A1 Prosthetic implant and methods of use for therapeutic gene expression |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083930A1 Insulin supplemented infant formula |
| 03/21/2001 | EP1083929A2 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083924A1 Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1083922A2 Composition and method for treatment of pseudomonas |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083918A1 Novel therapeutic agents that modulate 5-ht receptors |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083915A1 Compositions and methods for enhancing protein anabolism and detoxification |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083896A1 Use of neomycin for treating angiogenesis-related diseases |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP1083872A1 Pipecolic acid derivative hair growth compositions and uses |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288467A Compounds with growth hormone releasing properties |
| 03/21/2001 | CN1288387A Sustained release compositions, process for producing the same and utilization thereof |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288057A Coded novel human angiotensin II-1 receptor related protein gene, and application and prepn. method therefor |
| 03/21/2001 | CN1288056A Novel human coagulation thrombus protein-1 media factor, the application and prepn. method therefor |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1287860A Application of thyroxine for treating tumor |
| 03/21/2001 | CN1063331C Health medicine prepared by using fungus, marine, alga and Chinese herbal medicines as main raw materials |
| 03/20/2001 | US6204377 Kojibiose phosphorylase glucosyl-saccharides produced by transglycosylation |
| 03/20/2001 | US6204374 Cell cycle regulatory gene |
| 03/20/2001 | US6204372 DNA encoding a human tubby homolog |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204370 MN gene and protein |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204360 Peptide; for the treatment of viral, neoplastic and immunological diseases |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204308 Microencapsulating an active agent wherein a water-in-oil emulsion, containing a matrix-forming polymer and an active agent, is dispersed in an aqueous external phase to form a microencapsulated product; especially polyethylene carbonate |
| 03/20/2001 | US6204279 Secondary amide containing benzoxazole derivatives |
| 03/20/2001 | US6204268 Cyclic diaza compounds |
| 03/20/2001 | US6204263 Thrombin inhibitors. |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6204253 The uses of the identified polypeptides in therapeutic compositions to treat aberrant cell division in humans. the oncoprotein mdm2 (murine double minutes), and more specifically, agents which interact therewith. |
| 03/20/2001 | US6204251 Ocular gene therapy |
| 03/20/2001 | US6204248 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6204245 Treatment of narcolepsy with immunosuppressants |
| 03/20/2001 | US6204244 Amino acid compositions and use thereof in immunosuppression |
| 03/20/2001 | US6204242 Method for treating rheumatoid arthritis with composition containing histone |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204240 TGF-β1 to improve neural outcome |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204054 Transcytosis vehicles and enchancers for drug delivery |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204036 Stable, freeze dried mixture; parenteral administering |
| 03/20/2001 | US6204035 Enzymatic protein associated with modulation of coagulation; for preparing tissues, and organs for grafting; anticoauglant; for diagnosis of defective coagulation in humans; for treating autoimmune and inflammatory diseases |
| 03/20/2001 | US6204023 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204020 DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204014 Polynucleotide which encodes a helicase polypeptide of defined amino acid sequence; drug screening of bactericides, enzyme inhibitors, antibiotics |
| 03/20/2001 | US6204007 Antibodies against E-selectin |
| 03/20/2001 | US6204003 Methods for the diagnosis of feline infectious anemia |
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene |
| 03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |